Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Aerie Pharma (AERI) at Buy
-
Cantor Fitzgerald Starts Alimera Sciences (ALIM) at Buy
-
Notable Mergers and Acquisitions 1/5: (UUUU)/(URZ) (BDC) (DDD) (PFE)
-
Energy Fuels, Inc. (UUUU) to Acquire Uranerz Energy (URZ)
-
Organovo (ONVO) Reports $33M Controlled Equity Offering
-
Magellan Petroleum (MPET) Reports $10M Controlled Equity Offering
-
Radius Health (RDUS) PT Raised to $52 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Red Hat (RHT) at Buy
-
Immunogen (IMGN) PT Cut to $9 at Cantor Fitzgerald
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $40 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Durect Corp (DRRX) at Hold
-
Energy XXI Names Jim LaChance and Norm Louie to Board of Directors
-
Alimera Sciences (ALIM) Closes $50M Financing Arrangement with Deerfield
-
Notable Analyst Rating Changes 12/10: (SNSS) (AAL) (EQT) Upgraded; (S) (MPO) (ALLT) Downgraded
-
Pre-Open Stock Movers 12/10: (SNSS) (RVLT) (COST) Higher; (GDP) (ALLT) (YUM) Lower (more...)
-
UPDATE: Cantor Fitzgerald Upgrades Sunesis Pharmaceuticals (SNSS) to Buy; Analyst Thinks FDA Will Consider NDA
-
Orchid Island Capital Announces December 2014 Monthly Dividend and November 28, 2014 RMBS Portfolio Characteristics
-
Energy XXI to Present at CapitalOne 2014 Securities Energy Conference
-
StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event
-
Cantor Fitzgerald Downgrades Associated Estates Realty (AEC) to Hold
-
Orchid Island Capital Announces November 2014 Monthly Dividend and October 31, 2014 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Starts Cerus (CERS) at Buy
-
Tableau Software (DATA) Price Target Raised to $130 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell
-
Energy XXI Reports Fiscal 2015 First-Quarter Results, Issues Operations Update
-
Chimerix (CMRX) Closes 4.2M Common Offering
-
Energy XXI Declares Regular Quarterly Dividends on Common and Preferred Shares
-
Streetinsider.com's Hot Lunchtime Reads 11/4: (GPRO) (AAPL) (GALE) (BABA)
-
Alibaba (BABA) Price Target Raised to $110 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Digital Realty Trust (DLR) to Sell
-
Cantor Fitzgerald Downgrades Extra Space Storage (EXR) to Hold
-
Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Hold
-
Cantor Fitzgerald Comments on Juniper's (JNPR) Investor Day
-
Cantor Fitzgerald Starts Achaogen (AKAO) at Buy
-
Cantor Fitzgerald Starts Celsion Corp (CLSN) at Buy
-
Facebook (FB) PT Trimmed to $82 at Cantor Fitzgerald on Aggressive 2015 Investment Outlook
-
Cantor Fitzgerald Downgrades Apricus Biosciences (APRI) to Hold
-
Orchid Island Capital Announces Third Quarter 2014 Results
-
Cantor Fitzgerald Starts Rosetta Genomics (ROSG) at Hold
-
BGC Partners (BGCP) Commences $5.25/Share Tender for GFI Group (GFIG)
-
Apple (AAPL) PT Lifted to Street High $143 at Cantor Fitzgerald
-
Pre-Open Stock Movers 10/16: (EGLE) (IBIO) (MSO) (CHK) Higher; (NFLX) (EXTR) (TZOO) (BHI) Lower (more...)
-
Chimerix (CMRX) Price Target Raised to $39 at Cantor Fitzgerald
-
Streetinsider.com's Hot Lunchtime Reads 10/15: (LUV) (TSLA) (GALE) (SD)
-
Market Could Be Bottoming, Suggests Cantor Fitzgerald
-
Cantor Fitzgerald Comments on Apple (AAPL) Ahead of Thursday's Event
-
Cantor Fitzgerald Upgrades Endo Health (ENDP) to Hold
-
Netflix (NFLX): International Could Drive Upside in Q3 Subscriber Growth, Says Cantor
-
AutoGenomics (AGMX) Files $60M IPO
-
Radius Health (RDUS) Closes 3.13M Common Stock Offering for Net Proceeds of $53.3M


